danahutchinson.bsky.social
@danahutchinson.bsky.social
Pharmacologist/physiologist working on obesity and diabetes research.
So honoured and excited to be part of this work headed by Atrogi Sweden. A biased b2AR agonist for diabetes and obesity therapy.
June 23, 2025 at 9:49 PM
Date night
April 10, 2025 at 8:45 AM
Reposted
The time is now: accounting for time-of-day effects to improve reproducibility and translation of metabolism research | Nature Metabolism
Great collaboration led by Satchin Panda and team! Happy to contribute.
Time to take timing into consideration!!
www.nature.com/articles/s42...
The time is now: accounting for time-of-day effects to improve reproducibility and translation of metabolism research - Nature Metabolism
This broad group of authors summarizes the impact of circadian factors on metabolic biology and offers recommendations on how to account for and report biological, environmental and experimental facto...
www.nature.com
March 17, 2025 at 7:40 PM
Hubby injuired his back but still going out for our date...

With my bestie instead
March 21, 2025 at 7:40 AM
So proud that my first bluesky post is to highlight the fantastic review my PhD student Tim Roberts. Congratulations!

Advances in incretin therapies for targeting cardiovascular disease in diabetes - Journal of Molecular and Cellular Cardiology www.jmcc-online.com/article/S002...
Advances in incretin therapies for targeting cardiovascular disease in diabetes
The global prevalence of obesity is skyrocketing at an alarming rate, with recent data estimating that one-in-eight people are now living with the disease. Obesity is a chronic metabolic disorder that...
www.jmcc-online.com
March 14, 2025 at 12:28 AM